Neurimmune AG

www.neurimmune.com

Wagistrasse 13
Schlieren
Zurich
8952
Switzerland

Activities

Pharmaceutical

Related Content

Astrazeneca to develop and commercialise Neurimmune antibody
Astrazeneca to develop and commercialise Neurimmune antibody
Biogen and Neurimmune announce option exercise for Aducanumab
Biogen and Neurimmune announce option exercise for Aducanumab